In a systematic review by the International Society of Geriatric Oncology on adjuvant chemotherapy and gene expression profiling (GEP) in older patients with (HR)-positive, HER2-negative breast cancer, the authors identified 8 publications on the use of chemotherapy and 5 publications on GEP [41]. The gene discussed is ERBB2; the disease is breast carcinoma.